Bill Sponsor
Virginia House Bill 1187
Session 2024
Xylazine; penalty for manufacturing, selling, etc., for human consumption.
Became Law
Became Law
Signed by Governor on Apr 4, 2024
First Action
Jan 10, 2024
Latest Action
Apr 4, 2024
Origin Chamber
House
Type
Bill
Bill Number
1187
State
Virginia
Session
2024
Sponsorship by Party
Republican
Primary
House Votes (3)
Senate Votes (4)
Motion Text
VOTE: Block Vote Passage (99-Y 0-N)
House Roll Call Votes
Summary
Schedule III drugs. Adds xylazine to thelist of Schedule III drugs. Xylazine; manufacturing; selling; giving; distributing; possessing; veterinary use exemption; penalties. Provides that any person who knowingly manufactures, sells, gives, distributes, or possesses with the intent to manufacture, sell, give, or distribute the substance xylazine, when intended for human consumption, is guilty of a Class 5 felony. Under the bill, any person who knowingly possesses xylazine, when intended for human consumption, is guilty of a Class 1 misdemeanor. Under the bill, it is not an offense to (i) manufacture xylazine for legitimate veterinary use; (ii) distribute or sell xylazine for authorized veterinary use; (iii) possess, administer, prescribe, or dispense xylazine in good faith for use by animals within the course of legitimate veterinary practice; or (iv) possess or administer xylazine pursuant to a valid prescription from a licensed veterinarian. This bill is identical to SB 614.
Sources
Record Created
Jan 10, 2024 10:20:22 PM
Record Updated
Apr 24, 2024 12:13:25 AM